000 01191 a2200289 4500
005 20250513161242.0
264 0 _c19990125
008 199901s 0 0 eng d
022 _a0959-8049
040 _aNLM
_beng
_cNLM
100 1 _aPrior, C
245 0 0 _aComments on Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group, van Zandwijk et al., Eur J Cancer 1997, 33, 1759-1766.
_h[electronic resource]
260 _bEuropean journal of cancer (Oxford, England : 1990)
_cSep 1998
300 _a1638 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCarcinoma, Small Cell
_xtherapy
650 0 4 _aClinical Trials, Phase III as Topic
650 0 4 _aHumans
650 0 4 _aInterferon-gamma
_xtherapeutic use
650 0 4 _aLung Neoplasms
_xtherapy
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aRecombinant Proteins
700 1 _aThaler, J
700 1 _aHuber, H
773 0 _tEuropean journal of cancer (Oxford, England : 1990)
_gvol. 34
_gno. 10
_gp. 1638
999 _c9855395
_d9855395